Investigating the function of the OSM-OSMR axis in pancreatic ductal adenocarcinoma (PDAC)

被引：0
|
作者：
Sui, Yuan
Hunter, Tony
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-6984
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6984
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Heterocellular OSM-OSMR signalling reprograms fibroblasts to promote pancreatic cancer growth and metastasis
    Lee, Brian Y.
    Hogg, Elizabeth K. J.
    Below, Christopher R.
    Kononov, Alexander
    Blanco-Gomez, Adrian
    Heider, Felix
    Xu, Jingshu
    Hutton, Colin
    Zhang, Xiaohong
    Scheidt, Tamara
    Beattie, Kenneth
    Lamarca, Angela
    McNamara, Mairead
    Valle, Juan W.
    Jorgensen, Claus
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [2] Heterocellular OSM-OSMR signalling reprograms fibroblasts to promote pancreatic cancer growth and metastasis
    Brian Y. Lee
    Elizabeth K. J. Hogg
    Christopher R. Below
    Alexander Kononov
    Adrian Blanco-Gomez
    Felix Heider
    Jingshu Xu
    Colin Hutton
    Xiaohong Zhang
    Tamara Scheidt
    Kenneth Beattie
    Angela Lamarca
    Mairéad McNamara
    Juan W. Valle
    Claus Jørgensen
    Nature Communications, 12
  • [3] Targeting Pancreatic Ductal Adenocarcinoma (PDAC)
    Parrasia, Sofia
    Zoratti, Mario
    Szabo, Ildiko
    Biasutto, Lucia
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2021, 55 (01) : 61 - 90
  • [4] Role of the gut-tumor microbial axis in pancreatic ductal adenocarcinoma (PDAC).
    McAllister, Florencia
    CANCER RESEARCH, 2020, 80 (22)
  • [5] Overexpression of Mesothelin in Pancreatic Ductal Adenocarcinoma (PDAC)
    Le, Kai
    Wang, Jia
    Zhang, Tao
    Guo, Yifan
    Chang, Hong
    Wang, Siyuan
    Zhu, Bin
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2020, 17 (04): : 422 - 427
  • [6] Pancreatic ductal adenocarcinoma (PDAC) early detection
    Hinestrosa, Juan P.
    Dhani, Harmeet
    Schroeder, Gregor
    Lewis, Jean M.
    Balcer, Heath I.
    Kurzrock, Razelle
    Keith, Dove
    Sears, Rosalie
    Billings, Paul
    CANCER RESEARCH, 2023, 83 (07)
  • [7] Therapeutic trends in pancreatic ductal adenocarcinoma (PDAC)
    Chandana, Sreenivasa
    Babiker, Hani M.
    Mahadevan, Daruka
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2019, 28 (02) : 161 - 177
  • [8] Prognostic Metabolic Signatures in Pancreatic Ductal Adenocarcinoma (PDAC).
    Karasinska, Joanna
    Kalloger, Steve
    Wong, Hui-Li
    Renouf, Daniel
    Schaeffer, David
    LABORATORY INVESTIGATION, 2018, 98 : 680 - 680
  • [9] The Beginning of the End of Nihilism in Pancreatic Ductal Adenocarcinoma (PDAC)?
    Johnson, K. M.
    Firpo, M. A.
    Boucher, K. M.
    Scaife, C. L.
    Mulvihill, S. J.
    PANCREAS, 2013, 42 (08) : 1357 - 1357
  • [10] Everolimus for the treatment of advanced pancreatic ductal adenocarcinoma (PDAC)
    Babiker, Hani M.
    Karass, Michael
    Recio-Boiles, Alejandro
    Chandana, Sreenivasa R.
    McBride, Ali
    Mahadevan, Daruka
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2019, 28 (07) : 583 - 592
12345